Maryland Heights, MO, July 08, 2016 --(PR.com
)-- According to a new market research report published by iHealthcareAnalyst, Inc., Primary Immunodeficiency Diseases Market – Global PI Diseases, Tests and Treatment Analysis and Forecast 2013-2020, the global primary immunodeficiency diseases market is estimated to reach USD 5.8 Billion in 2020, expanding at a CAGR of 6.7% from 2016 to 2020.
Visit the Primary Immunodeficiency Diseases Market – Global PI Diseases, Tests and Treatment Analysis and Forecast 2013-2020 report at http://www.ihealthcareanalyst.com/report/primary-immunodeficiency-diseases-market/
Primary immunodeficiency diseases or disorders (PIDD or PI) are caused as part of the body's immune system is missing or does not function normally, such that it is an inherited flaw in the immune system that increases the susceptibility to infections. Besides susceptibility to infections, PIDD may cause other health problems as well, including allergies, asthma, swollen joints, digestive tract problems, growth problems or an enlarged liver and spleen. The global primary immunodeficiency diseases market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the disease types (antibody deficiency – agammaglobulinaemia, common variable immune deficiency, IgG subclass deficiency, SIgAD; cellular immunodeficiency - ataxia telangiectasia, DiGeorge syndrome, hyper IgM syndromes, Wiskott-Aldrich syndrome; innate immune disorders - complement deficiencies, and hyper IgE syndrome) and test types (blood and prenatal testing), treatment types (immunoglobulin replacement therapy, antibiotics therapy, stem cell and gene therapy, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends in strategic management.
The global primary immunodeficiency diseases market is segmented as:
1. Disease Type
1.1. Antibody Deficiency
1.1.2. Common Variable Immune Deficiency
1.1.3. IgG Subclass Deficiency
1.1.4. Selective IgA Deficiency (SIgAD)
1.2. Cellular Immunodeficiency
1.2.1. Ataxia Telangiectasia
1.2.2. DiGeorge Syndrome
1.2.3. Hyper IgM Syndromes
1.2.4. Wiskott-Aldrich Syndrome
1.3. Innate Immune Disorder
1.3.1. Complement Deficiencies
1.3.2. Hyper IgE Syndrome
2. Test Type
2.1. Blood Testing
2.2. Prenatal Testing
3. Treatment Type
3.1. Immunoglobulin Replacement Therapy
3.2. Antibiotics Therapy
3.3. Stem cell and Gene Therapy
4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World
5. Company Profiles
5.1. Baxter International, Inc.
5.2. Bio Products Laboratory
5.3. Biotest AG
5.4. CSL Behring LLC
5.5. Grifols S.A.
5.6. Kedrion S.p.A.
5.7. LFB S.A.
5.8. Octapharma AG
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043